Jochem Potenberg
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Oncology top 5%
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
Papers in
-
- Breast Cancer Treatment Studies 16
- Carcinogens and Genotoxicity Assessment 3
- Oncology 11
- HER2/EGFR in Cancer Research 8
- Bone health and treatments 1
- Co-authors
- Michael Ståhl (1 shared paper)Ralf‐Dieter Hofheinz (2 shared papers)Susanna Hegewisch‐Becker (1 shared paper)Georg Bolz (1 shared paper)Deniz Gencer (1 shared paper)Salah‐Eddin Al‐Batran (1 shared paper)Andreas Schneeweiss (1 shared paper)Ursula Kronawitter (1 shared paper)
- Journals
- Annals of Oncology (9 papers)Journal of Clinical Oncology (3 papers)The Lancet Oncology (2 papers)The Breast (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- GermanySwitzerlandItaly
In The Last Decade
Jochem Potenberg
29 papers receiving 1.3k citations
Jochem Potenberg's Hit Papers
Peers
Comparison fields: 5 of 50
- Cancer Research 745
- Oncology 401
- Reproductive Medicine 66
- Dermatology 52
- Genetics 101
Countries citing papers authored by Jochem Potenberg
This map shows the geographic impact of Jochem Potenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochem Potenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochem Potenberg more than expected).
Fields of papers citing papers by Jochem Potenberg
This network shows the impact of papers produced by Jochem Potenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochem Potenberg. The network helps show where Jochem Potenberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Jochem Potenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Hit paper breakdown → | 2022 | 329 |
| 2 | 2020 | 139 | |
| 3 | 2017 | 127 | |
| 4 | 2014 | 113 | |
| 5 | 2017 | 109 | |
| 6 | 2017 | 100 | |
| 7 | 2018 | 92 | |
| 8 | 2015 | 61 | |
| 9 | 2022 | 60 | |
| 10 | 2015 | 50 | |
| 11 | 2023 | 30 | |
| 12 | 2020 | 28 | |
| 13 | 2023 | 28 | |
| 14 | 2021 | 15 | |
| 15 | 2023 | 13 | |
| 16 | 2021 | 11 | |
| 17 | 2022 | 9 | |
| 18 | 1986 | 8 | |
| 19 | 1988 | 8 | |
| 20 | 2021 | 8 |
About Jochem Potenberg
Jochem Potenberg is a scholar working on Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging, Dermatology and Radiation, having authored 30 papers that have together received 1.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (16 papers), HER2/EGFR in Cancer Research (8 papers), Carcinogens and Genotoxicity Assessment (3 papers), MRI in cancer diagnosis (2 papers), Gastric Cancer Management and Outcomes (2 papers), Advanced Radiotherapy Techniques (1 paper), Breast Lesions and Carcinomas (1 paper) and Bone health and treatments (1 paper). The work is most often cited by research in Cancer Research (745 citations), Oncology (401 citations), Reproductive Medicine (66 citations), Dermatology (52 citations) and Genetics (101 citations). Jochem Potenberg has collaborated with scholars based in Germany, Switzerland and Italy. Frequent co-authors include Michael Ståhl, Ralf‐Dieter Hofheinz, Susanna Hegewisch‐Becker, Georg Bolz, Deniz Gencer, Salah‐Eddin Al‐Batran, Andreas Schneeweiss, Ursula Kronawitter, Regine Kahl and Raquel von Schumann. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, The Lancet Oncology, The Breast and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.